Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5UFL

Crystal structure of a CIP2A core domain

Summary for 5UFL
Entry DOI10.2210/pdb5ufl/pdb
DescriptorProtein CIP2A, ZINC ION (2 entities in total)
Functional Keywordscip2a, pp2a, signaling protein
Biological sourceHomo sapiens (Human)
Cellular locationMembrane ; Single-pass membrane protein : Q8TCG1
Total number of polymer chains2
Total formula weight124715.67
Authors
Wang, Z.,Wang, J.,Rao, Z.,Xu, W. (deposition date: 2017-01-04, release date: 2017-02-15, Last modification date: 2024-03-06)
Primary citationWang, J.,Okkeri, J.,Pavic, K.,Wang, Z.,Kauko, O.,Halonen, T.,Sarek, G.,Ojala, P.M.,Rao, Z.,Xu, W.,Westermarck, J.
Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56.
EMBO Rep., 18:437-450, 2017
Cited by
PubMed Abstract: Protein phosphatase 2A (PP2A) is a critical human tumor suppressor. Cancerous inhibitor of PP2A (CIP2A) supports the activity of several critical cancer drivers (Akt, MYC, E2F1) and promotes malignancy in most cancer types via PP2A inhibition. However, the 3D structure of CIP2A has not been solved, and it remains enigmatic how it interacts with PP2A. Here, we show by yeast two-hybrid assays, and subsequent validation experiments, that CIP2A forms homodimers. The homodimerization of CIP2A is confirmed by solving the crystal structure of an N-terminal CIP2A fragment (amino acids 1-560) at 3.0 Å resolution, and by subsequent structure-based mutational analyses of the dimerization interface. We further describe that the CIP2A dimer interacts with the PP2A subunits B56α and B56γ. CIP2A binds to the B56 proteins via a conserved N-terminal region, and dimerization promotes B56 binding. Intriguingly, inhibition of either CIP2A dimerization or B56α/γ expression destabilizes CIP2A, indicating opportunities for controlled degradation. These results provide the first structure-function analysis of the interaction of CIP2A with PP2A/B56 and have direct implications for its targeting in cancer therapy.
PubMed: 28174209
DOI: 10.15252/embr.201642788
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3 Å)
Structure validation

238895

数据于2025-07-16公开中

PDB statisticsPDBj update infoContact PDBjnumon